Augmented activity of adenosine triphosphate-sensitive K+ channels induced by droperidol in the rat aorta

Anesthesia and Analgesia

Volumn 102, Issue 3, 2006, Pages 786-791

  Kinoshita, Hiroyuki ^a   Dojo, Mayuko ^a   Nakahata, Katsutoshi ^a   Kimoto, Yoshiki ^a   Kakutani, Tetsuya ^a   Mizumoto, Kazuhiro ^a   Hatano, Yoshio ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ALPHA ADRENERGIC RECEPTOR; DIMETHYL SULFOXIDE; DROPERIDOL; GLIBENCLAMIDE; LEMAKALIM; PHENTOLAMINE; PHENYLEPHRINE;

ANIMAL EXPERIMENT; AORTA MEDIA; ARTICLE; CARDIAC PATIENT; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; HEART MUSCLE CELL; HYPERPOLARIZATION; MALE; MEMBRANE POTENTIAL; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; QT PROLONGATION; RAT; SMOOTH MUSCLE FIBER; VASCULAR RING; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 33644520571     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000195441.14929.6d     Document Type: Article

References (32)

1. Drolet B, Zhang S, Deschenes D, et al. Droperidol lengthens cardiac repolarization due to block of the rapid component of the delayed rectifier potassium current. J Cardiovasc Electrophysiol 1999;10:1597-604.
2. Habib AS, Gan TJ. Food and Drug Administration black box warning on the perioperative use of droperidol: a review of the cases. Anesth Analg 2003;96:1377-9.
3. Quayle JM, Nelson MT, Standen NB. ATP-sensitive and inwardly rectifying potassium channels in smooth muscle. Physiol Rev 1997;77:1165-232.
4. Kinoshita H, Katusic ZS. Role of potassium channels in relaxations of isolated canine basilar arteries to acidosis. Stroke 1997;28:433-8.
5. + channels. Anesthesiology 2001;95:200-6.
6. Muldoon SM, Janssens WJ, Verbeuren TJ, Vanhoutte PM. Alpha-adrenergic blocking properties of droperidol on isolated blood vessels of the dog. Br J Anaesth 1977;49:211-6.
7. Van Nueten JM, Reneman RS, Janssen PAJ. Specific α-adrenoceptor blocking effect of droperidol on isolated smooth muscles. Eur J Pharmacol 1977;44:1-8.
8. + channels in human omental artery. Arterioscler Thromb Vasc Biol 2004;24:1-6.
9. + channels and the role of kinases in the porcine coronary artery. Anesthesiology 2005;102:581-587
10. Olschewski A, Hempelmann G, Vogel W, Safronov BV. Suppression of potassium conductance by droperidol has influence on excitability of spinal sensory neurons. Anesthesiology 2001;94:280-9.
11. Friederich P, Urban BW. Interaction of intravenous anesthetics with human neuronal potassium currents in relation to clinical concentrations. Anesthesiology 1999;91:1853-60.
12. + channel openers. Pharmacol Ther 2000;85:39-53.
13. Kawano T, Oshita S, Takahashi A, et al. Molecular mechanisms underlying ketamine-mediated inhibition of sarcolemmal adenosine triphosphate-sensitive potassium channels. Anesthesiology 2005;102:93-101.
14. + channel openers. Mol Pharmacol 1999;56:308-315
15. + channel openers. J Vasc Res 1993;30:2-12
16. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 1995;268:C799-822.
17. Kuriyama H, Kitamura K, Nabata H. Pharmacological and physiological significance of ion channels and factors that modulate them in vascular tissues. Pharmacological Rev 1995;47:387-573.
18. + channels in augmented relaxations to sodium nitroprusside induced by mexiletine in rat aortas. Anesthesiology 2000;92:813-20.
19. ATP channels in vascular smooth muscles. Circ Res 2003;92:1225-32.
20. + channel activation by calcitonin gene-related peptide and protein kinase A in pig coronary arterial smooth muscle. J Physiol 1998;507:117-29.
21. Chen SJ, Wu CC, Yang SN, et al. Hyperpolarization contributes to vascular hyporeactivity in rats with lipopolysaccharide-induced endotoxic shock. Life Sci 2000;68:659-68.
22. Siegel G, Rückborn K, Schnalke F, Grote J. Membrane physiological reactions of human arteriosclerotic coronary arteries to hypoxia. J Cardiovasc Pharmacol 1992;20:S217-20.
23. Cressman WA, Plostnieks J, Johnson PC. Absorption, metabolism and excretion of droperidol by human subjects following intramuscular and intravenous administration. Anesthesiology 1973;38:363-9.
24. Fischler M, Bonnet F, Trang H, et al. The pharmacokinetics of droperidol in anesthetized patients. Anesthesiology 1986;64:486-9.
25. + channels mediate dilatation of cerebral arterioles during hypoxia. Circ Res 1994;74:1005-8.
26. Ishizaka H, Kuo L. Acidosis-induced coronary arteriolar dilation is mediated by ATP-sensitive potassium channels in vascular smooth muscle. Circ Res 1996;78:50-7.
27. ATP-channels. Br J Pharmacol 1997;120:728-34.
28. + channels in cerebral ischemic preconditioning. Proc Natl Acad Sci USA 1995;92:4666-70.
29. ATP channels and myocardial preconditioning: an update. Am J Physiol 2003;285:H921-30.
30. Cook NS. The pharmacology of potassium channels and their therapeutic potential. Trends Pharmacol Sci 1988;9:21-8.
31. Liu M-H, Floten S, Furnary AP, et al. Effects of potassium channel opener aprikalim on the receptor-mediated vasoconstriction in the human internal mammary artery. Ann Thorac Surg 2001;71:636-41.
32. Müller-Ehmsen J, Brixius K, Hoischen S, Schwinger HG. Inotropic and coronary vasodilatory actions of the K-adenosine triphosphate channel modulator nicorandil in human tissue. J Pharmacol Exp Ther 1996;279:1220-8.